11 September 2017

Publication of supplementary prospectus by Aviva plc

The following supplementary prospectus has been approved by the United Kingdom Listing Authority (the "UKLA") and is available for viewing:

Supplementary prospectus dated 11 September 2017 (the "Supplement") to the base prospectus dated 12 May 2017 relating to the £7,000,000,000 Euro Note Programme of Aviva plc (the "Issuer"). The programme enables the Issuer to issue debt instruments including a range of hybrid securities.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/4202Q_-2017-9-11.pdf

The Supplement and the documents incorporated by reference therein are being submitted to the National Storage Mechanism and will shortly be available for inspection at www.hemscott.com/nsm.do 

Enquiries:

Analysts

Chris Esson                                                                                        +44 (0)20 7662 8115

Diane Michelberger                                                                             +44 (0)20 7662 0911

Aviva plc

St Helen's, 1 Undershaft

London EC3P 3DQ

Registered in England

Number 2468686

This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or any relevant securities laws of any state of the United States, and are subject to US tax law requirements. Subject to certain exceptions, the securities referred to herein may not be offered, sold or delivered in the United States, as defined in Regulation S under the Securities Act. The prospectus may not be accessed from, or transmitted in or into, the United States. Accordingly, these securities may not be offered, sold or delivered in the United States.

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirements.

END